Flow cytometry discriminates particle associated fluorescence from the fluorescence of the surrounding medium. It permits assemblies of macromolecular complexes on beads or cells to be detected in real-time with precision and specificity. We have investigated two types of robust sample handling systems which provide sub-second resolution and high throughput: 1) mixers which use stepper-motor driven syringes to initiate chemical reactions in msec time frames; and 2) flow injection controllers with valves and automated syringes used in chemical process control. In the former system, we used fast valves to overcome the disparity between mixing 100 pus of sample in 100 msecs and delivering sample to a flow cytometer at 1tIJsec. Particles were detected within 100 msec after mixing, but unstable flow was created which lasted for 1 sec after injection of the sample into the flow cytometer. We used optical criteria to discriminate particles which were out of alignment due to the unstable flow. Complex sample handling protocols involving multiple mixing steps and sample dilution have also been achieved. With the latter system we were able to automate sample handling and deliveiy with intervals ofa few seconds. We used a fluidic approach to defeat the instability caused by sample introduction. By controlling both sheath and sample with individual syringes, the period of instability was reduced to -2OO msecs. Automated sample handling and subsecond resolution should permit broad analytical and diagnostic applications offlow cytometiy.
INTRODUCTION
There are several complementaiy goals for handling biological samples for research and industrial applications. In particular, there is a need for assay systems which are robust, sensitive, quantitative, and compatible with high throughput screening for both cells and isolated molecules. In several accompanying articles from this symposium we provide evidence for the utility of flow cytometry as a tool for the investigation of molecular interactions of native molecules on cells and purified molecules on beads.
Flow cytometry is based upon detecting the fluorescence and light scatter signals of particles flowing in a stream past a laser beam. The particles are aligned upon exiting a small nozzle and hydrodynamically focused by coaxial flow of the sample stream within a flowing sheath. The utility of time-base flow cytometry has been recognized for some time (Martin and Schwartzendruber, 1981) . Flow cytometry is now routinely used for observing continuously both the binding of soluble molecules to cell surface molecules and cell activation which occurs in response to the binding interaction (Skiar, 1987; Nolan et al., 1998) . If cell responses are occurring in time frames of seconds, then one can imagine that the molecular binding events which precede them may include sub-second steps. Over the past decade, there have been numerous designs which provided on4ine sample addition of reagents to cell suspensions as they pass through a flow cytometer (Dive et a!., 1987; Kachel Ct a!., 1982; Kelly, 1989; Lindberg et a!., 1995; Omann et a!. 1985) . There were two common limitations to the time resolution of these early devices. First, if the flow rate of the sample was 1 tl/sec between the point that it was being mixed and the point it was being observed in the flow cytometer and the volume between these points was several pis, then several seconds could elapse between mixing and observation. The second problem concerns the uncertainty of the efficiency of mixing. Diffusional mixing is slow in large volumes, and even magnetic stir bars requires several seconds for homogeneous mixing ofseveral mis.
Our approach has been to adapt rapid mixing technology to flow cytometry (Nolan CtaL, 1995) . This approach enables complete mixing, sample delivery, and initiation of measurement in 300 msecs. The mixing occurs through the delivery of cells and reagents through a mixing tee. The main obstacle to measurements at earlier times is the instability which occurs in the nozzle immediately after the volume between the sample line and the nozzle of the flow cytometer is cleared. The instability occurs because the dead volume of a few microliters must be cleared with sample flow at a rate greater than can be accommodated by laminar flow in the nozzle. At flow rates common to flow cytometers, the instability was detected for -1 second after the sample was "injected" into the nozzle. By including in the analysis only those particles which remained aligned in the stream, we were able to obtain times as early as 300 msecs after mixing. The unifonnity of mixing was verified by showing that quenching reactions involving fluorescent beads and soluble quenchers were complete by the time the particles were observed.
Recently, coaxial mixing of a sample stream and a reagent stream has allowed time points as early as 100 msec (Scampavia et a!., 1995) . This approach does not require an instability-inducing boost to clear a dead volume rapidly for early time measurements. Rather, sample and reagent flow continuously, and the age of the mixed sample depends upon the point of measurement relative to the point of mixing. Rapid mixing and coaxial mixing are fundamentally different in their approaches and capabilities. While the coaxial approach is free of unstable sample delivery, enabling measurements at veiy early times after mixing, it measures only a single time point in each experiment. The mixing apparatus is physically repositioned prior to the measurement of each subsequent time point. The ability to continuously monitor a single time point allows an unlimited number of cells to be measured at each time point for excellent statistics and this would be an ideal way to analyze and even sort for a sub-population of cells which responds to a stimulus within a defined time window. On the other hand, with stopped flow mixing, once the instability has passed, the kinetics of fluorescence change is measured continuously providing the overall time course of a process. Further, it is difficult to conceive of a coaxial mixing geometiy which would enable complex mixing protocols. Such complex mixing schemes are extremely valuable for mechanistic studies of cellular and biochemical processes and for high throughput screening. Thus, at this point, the two approaches are somewhat complementary. While coaxial mixing provides superior resolution at early times by avoiding unstable flow, rapid mixing provides an experimentally flexible system. To further control the instability at early times following mixing we have adopted the strategy of simultaneously controlling sample and sheath (Seamer et al., submitted) . This approach also allows for the programmed delivery of small sample volumes in short time periods.
In this article, we describe the progress we have made in developing or integrating from commercial sources the appropriate tools for sample handling for cytometers. The developments include: 1) recent advances in sample mixing and sample delivery technology which allows kinetic flow cytometric measurements to be made in the sub-second time frame and 2) computerization of sample handling which allows for automation in sample delivery for high throughput screening.
METHODS
Cell Culture and Reagents. Human neutrophils were handled as described previously (Fay et al., 1991) . Human myeloid (U937) cell tranSfeCtantS expressing the human formyl peptide receptor were cultured in RPMJ media at 5% CO in T-75 flasks (Costar). Cells were pelleted by centrifugation, resuspended in buffer (30 mM HEPES, 1 10 mM NaCl, 10 mM KC1, 1 niM MgC12, 10 mM glucose, 1 mg/nil BSA, pH 7.3) at a concentration of 1X107/ml and stored on ice until use. The fluorescent formyl peptide (N-formyl-met-leu-phe-lys-FITC, Penninsula, Laboratories) was dissolved in DMSO at a concentration of 1 mM, and diluted to a working solution of -1 uM. Actual peptide concentrations were determined by absorbance at 490 nm using an extinction coefficient of 8. 1X104 M' cm' (see Fay et al., 1991) . A soluble unlabeled formyl peptide (f-met-leu-phe-phe-gly-gly-lys) and a low affinity labeled peptide (f-met-gly-phe-phe-lys-FITC) were synthesized by Commonwealth Biotechnologies, Inc. (Richmond, Va).
Calibration. The flow cytometer signal was calibrated using standardized fluorescein microspheres (Flow Cytometry Standards Corp. San Juan, PR). Data were analyzed using IDLYK software (NFCR, LANL). Cells were gated using forward and 900 light scatter, and the mean fluorescence at vs. time was calculated. Mean channel numbers were converted to ligand molecules per cell using the FITC standard bead data and the relative quantum yield (Q)ofconjugated fluorescein compared to free fluorescein as described in Fay et al. (1991) .
RAPID KINETIC FLOW CYTOMETRY
We have recently described a specialized flow cytometiy instrument at the National Flow Cytometry Resource, Los Alamos National Laboratory (Nolan et al, 1995) . The Rapid Mix Flow Cytometer (see Figure 1 ) uses the stepper-motor driven syringes of a Biologic SFM3 stopped flow mixing device to displace the contents of two sample loops through a mixing tee to a modified Becton Dickinson FACS II flow cytometer. The pitch of the screws of the stepper motors and the sizes of the syringes ofthe SFM-3 had been fixed by the manufacturer for applications which required mixing and delivery of hundreds of ds of sample in no more than 10's of milliseconds. The volumetric displacement of each sample loop is controlled individually by its own syringe.The software supplied by the manufacturer allowed each syringe and two fast external valves to be controlled in on/off positions.
In order to accommodate rapid delivery ofa sample to the flow cytometer, a number of modifications to the instrument had to be made. For optimal flexibility, we replaced the closed syringe and mixing system with syringes with Luer fittings and connected the syringes to manual sample loops and mixing tees. Because the slowest delivezy rate available was too high for stable sample flow, the pitch ofthe screw ofthe sample delivety syringe was reduced to accommodate the slow deliveiy rates required by the flow cytometer. In addition, the original software which controlled the syringes and the fast valves had a limit of nine control steps, each with a duration up to 10 seconds. Five of these steps are used to mix and direct sample to the flow cytometer, leaving four steps (40 seconds) for measurement. This limitation was exacerbated by the need for additional steps which could control a more complex mixing protocol such as a second mix. We modified the Biologic syringe control software code to allow up to 40 individual control steps, allowing kinetic measuremônts of over five minutes in duration. The resulting system has sufficient programming flexibility to allow a variety of sample mixing and dilution protocols. Figure 1 . Rapid Mix Flow Cytometer and Mixing Sequence. The mixer is connected to the cytometer by sample loops, mixing "T' or "X ", and delay lines. The device consists of three syringes (Si, S2, and S3) each driven by a stepper motor.
SAMPLE TUBE
Each syringe has a manual valve which allows the syringe to be filled with buffer or the syringe to be connected to the 250 tl sample loop. The sample loops are filled manually. The mixing of the sample occurs at the "X" where the lines from the 3 syringes meet. The sample is pushed through the delay line through Vi and V2. A nozzle holder with a 1.5 p1 dead volume holds a 3 way fast switching valve (Vi) to control sample flow to the cytometer. V2 controls sample flow to waste. The computer controlled mixing sequence has several phases. In the first phase, the valve position is initialized (25 msec volume delivered in tls during the listed time interval). These two steps advance the contents of the sample loops through the X, then mixes the contents of the sample loops, fills the delay line and expels any old sample beyond Vi and V2. Then, the system is allowed to relax for 50 msec to accommodate pressure changes that result from the mixing. The fast valves Vi and V2 are switched (20 msec) so that the sample flow is redirected toward the nozzle. The slow syringe (S3) is used to clear the dead volwne between Vi and the nozzle (50 msec). The mixed sample is delivered to the cytometer at a rate of 1.8 ui/sec. The cytometer retains the ability to operate in the traditional, or slow, sample deliveiy mode, drawing sample from a sample tube when the fast mixer is not being used. A voltage ramp triggered by the mixer computer logs the time base as a cytometer parameter. Two parameter histograms are analyzed and mean fluorescence vs. time is calculated.
Tests validated the performance of the instrument. Fluorescent beads were used to determine the early time detection, uniformity of mixing, and proportioning capability of the syringes. When beads were loaded into one of the sample loops and mixed with an equal volume of buffer, the beads appeared at the laser beam and fluorescence of the bead population was detectable within 300 msec. By gating the population on light scatter, it was possible to resolve cells positioned in the laser even though the sample flow was unstable. Complete mixing of sample in this time frame was demonstrated using potassium iodide to quench the fluorescence of beads surface labeled with F1TC. At the earliest times measured, the FITC fluorescence of beads mixed with iodide was quenched compared to samples mixed with buffer. This test confirms that sample mixing is complete by the time particles reach the laser beam. Further tests established the ability of the instrument to quantitatively proportion sample, a necessity for accurate dose-response studies. Cell studies, involving the formyl peptide receptor on neutrophils, were used to define binding and dissociation of fluorescent ligands. A description of the instrument design, operation, and testing has been published (Nolan et al. 1995) .
We have conducted physiological experiments to define the instrument capabilities. We examined the calcium response of neutrophils to a series of concentrations of formyl peptide (Fig. 2) . We examined the behavior of the cell populations We conducted a series of ligand binding experiments to further define the capabilities of the instrument. Fig. 3 shows the kinetics of formyl peptide ligand binding to neutrophils. After the sample mixing, the sample is boosted into the flow cytometer. Associated with the elevated sample flow is a transient instability during which the sample stream expands and the ligand detection is perturbed (Fig. 3A) . Because the perturbation is detected both in the total binding and non-specific binding kinetics, the specific binding (Fig. 3B) Two-Step Mixing. Two-step mixing experiments involve mixing cells with a ligand which stimulates the cells. Then the stimulus is inhibited by adding an antagonist to the same receptor. This allows a pulse of stimulation in which cell responses such as intracellular calcium or ligand binding and dissociation can be evaluated over time. We modified the rapid mix cytometer for double mix protocols by splitting the sample line from Si and adding a second mixing tee. In these experiments, Si was used to mix cells and fluorescent ligand in the first step, S2 was used to stop the binding of the ligand by adding non-fluorescent ligand, then S3 was used in the normal manner for sample boost and deliveiy. A schematic of this protocol is shown in Fig. 5 and the results for formyl peptide binding and dissociation on a transfected cell line are shown in Fig. 6 . We found that we were readily able to program multiple mixing steps within time frames shorter than 10 seconds. In principle, these steps can be compressed for sub.second processes. Figure 5 . Rapid Mix Flow Cytometer Configuration and Sequence for Double Mix Experiments. We reconfigured the sample and delay lines to enable one syringe to mix equal volumes from two sample loops, allowing the other syringe to displace the contents of a third sample loop in a second mixing step. This configuration is depicted schematically along with the control sequence for the Biologic syringes and the fast-acting solenoid valves. First, valve 2 (V2) is opened, so that all fluid is displaced to waste (Step 1). Syringe 1 (Si) is then activated to displace the contents of two sample loops through a mixing tee into the fir.st delay line (Di) (Step 2). In this step, buffer from Si is partitioned equally resulting in the mixing of equal volumes of reagents from these two sample ioops. The mixed sample is allowed to age in Di for the desired amount of time (
Step 3), before 52 and Si are activated to mix the contents of sample ioop 2 with the contents of Di through a second mixing tee into delay line 2 (D2) (Step 4). Once this second mixing step occurs, the remainder ofthe mixing protocol is the same as for a single step mix. There is a short (20-50 msec) waiting period to allow any instability from the second rapid mix to subside (Step 5), then V2 is closed and valve 1 (Vi) is opened (Step 6) so that all fluid is displaced to the cytometer.
The signal to open Vi also starts a voltage ramp, which provides the time base. The dead volume of the cytometer inlet line is rapidly displaced by a boost from S3 (50 msec, Step 7). The contents of D2 is delivered at a slow rate (1.8 ul/sec) tothe point of measurement (Step 8), and the fluorescence ofthe sample is measured.
Applications ofTwo-Step Mixing Experiments. In many cellular processes, the binding interactions between soluble ligands and cell surface molecules receptors change over time. Because the time frame of cell responses may be in seconds, the interactions between ligands and receptors and subsequent receptor signaling steps may occur in the sub second time frame. Mechanistic studies therefore require measurements of the time dependent changes on the appropriate time scale. One example of such experiments involve the addition of ligand to cells to allow bin4ing to occur for a short period of time, followed by addition of unlabeled ligand or antagonist to induce dissociation (Fig. 6 ). The figure compares two types of experiments: a binding experiment and a dissociation experiment. In the first experiment, cells and fluorescent ligand are . Two-step mixing for analysis of rapid time-dependent receptor evolution. Cells and labeled ligand were loaded into the two sample loops controlled by Si, and buffer plus unlabeled ligand was loaded into the sample loop controlled by S2. Si mixed the contents of the sample ioops in equal proportions. The mixed sample was then directed to the sheath stream to measure the association kinetics, or allowed to age in the delay line. After binding had proceeded for 3, 5, or 10 seconds, the contents of delay line 1 were mixed with the contents of sample loop 2 to fill delay line 2, and the twice mixed samples were delivered to the flow cytometer for measurement ofdissociation oflabeled ligand.
Another application under development is intended to extend the range of sensitivity of flow cytometry for detecting ligand binding. Our experience has shown that once ligand concentrations exceed -100 tM, it becomes difficult to evaluate ligand which is specifically associated with cellular receptors in conventional flow cytometiy. While it is possible to combine a manual washing step between the time that cells are labeled and the time they are analyzed in the flow cytometer, ligands with dissociation times shorter than the wash steps would be lost from the cell. With a rapid mix or multi mix capability, cells could be labeled with high concentrations of ligand, then a rapid dilution step could allow dilution of free ligand away from the cells and observation ofthe cells prior to the time in which bound ligand had dissociated from the receptors.
CONTROL OF SAMPLE INSTABILITY AND AUTOMATION
The system described above uses three syringes for controlling sample mixing and deliveiy but none of the syringes are available to control the sheath flow. We have investigated the possibility ofusing a syringe to control sheath flow so that total flow through the flow cell could remain constant during sample delivery. A schematic diagram of the Alitea FIA system is shown in Figure 7 . The flow4njection hardware supplied by the manufacturer was supplemented with additional syringe pumps and valves. The control software was also modified by the manufacturer to shorten the command cycle times. The unit consists of a control module with one internal valve, one external valve, three added external syringe pumps and progranunable Windows'TM based control software. Each of the syringes may be replaced with barrels ranging from 100 i.ds to 10 mis. At the present time, separate computers are used for FIA control and data acquisition for the flow cytometer. Figure 7 . Schematic of the FIA Flow Cytometer using the Alitea Control System. Si is a 0.5 ml syringe pump used to dispense sample (either cells or beads) to the mix line. S2 is a 1 ml syringe pump used to deliver reactant to the mix lineand then deliver the sample-reactant mixture to the flow cytometer. S3 is a 5 ml syringe pump used to dispense sheath buffer. Vi is a Valco 6-position valve, positioned as close to the flow cell sample-input port as possible, -3 cm. V2 is an identical valve used to direct the sheath buffer to the flow cell, during normal operation, redirecting sheath to the mixing line, for rinsing between samples. Flow cytometiy offers sensitivity for a variety ofbead or cell based assays of molecular assembly and cell response. These are likely to find basic, clinical, and commercial applications. We have investigated several types of robust sample handling systems. The first system, at a cost of -$5O,OOO was intended to provide optimal time resolution, but was limited by the number of its syringes to sample mixing and deliveiy. Unstable flow characteristics had to be resolved optically. However, multiple step mixing protocols could be performed. The second system, at a cost of -1O,OOOoffered flexibility, having the ability to control multiple valves, and syringes of variable barrel size and delivery rate. The system could be used to control both sheath and sample, allowing stable sample flow within 200 msecs of sample mixing. Both systems allow the potential of programmable, terminal control sample deliveiy. We are developing new systems which combine the best features of both.
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